The premature ejaculation treatment global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Premature Ejaculation Treatment Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The
premature ejaculation treatment market size has grown strongly in
recent years. It will grow from $3.53 billion in 2023 to $3.88 billion
in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth in
the historic period can be attributed to increasing prevalence of
premature ejaculation, growing awareness and reduced stigma, physician
and patient education, changing societal attitudes toward sexual health,
expansion of telemedicine services, pharmaceutical industry
initiatives..
The premature ejaculation treatment market size is expected to see strong growth in the next few years. It will grow to $5.62 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to continued focus on sexual health, individualized treatment approaches, global efforts to address sexual dysfunction, online health platforms and apps, increased openness in healthcare discussions.. Major trends in the forecast period include rise in behavioral and psychosexual therapies, development of novel topical therapies, advancements in pharmacological treatments, integration of telemedicine and online platforms, focus on patient education and counseling, research on novel mechanisms of action..
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/premature-ejaculation-treatment-global-market-report
Scope Of Premature Ejaculation Treatment Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Premature Ejaculation Treatment Market Overview
Market Drivers -
The
increasing prevalence of sexual disorders is expected to propel the
growth of the premature ejaculation treatment market going forward.
Sexual disorder or dysfunction refers to the difficulty faced by both
men and women during any phase of regular intimate activity. Premature
ejaculation is a sexual disorder where premature ejaculation treatment
involving medications or therapeutic approaches addresses and controls
this condition. For instance, in November 2021, according to a survey of
2,000 UK adults conducted by Pharmacy Direct GB, a UK-based online
pharmacy, around 48% of UK residents reported experiencing erectile
dysfunction, representing about 16.5 million individuals. The National
Health Service spent over $17,9 million (£13 million) for Erectile
Dysfunction treatment prescriptions in 2021. Further, in July 2022,
according to a survey of 1,000 men across the UK by Click2Pharmacy, a
UK-based provider of local prescription treatment services, around 58.2%
experienced erectile dysfunction in the UK and 3 in 4 men between the
ages of 25 and 34 experience erectile dysfunction in 2022. Therefore,
the increasing prevalence of sexual disorders is driving the growth of
the premature ejaculation treatment market.
Market Trends -
Major
companies operating in the premature ejaculation treatment market are
developing new solutions, such as delay sprays, to drive revenues in the
market. Delay sprays, specifically prepared products applied to the
penis before sexual activity to assist men last longer during sexual
intercourse, work by momentarily dulling penis nerves, lowering penis
sensitivity, and postponing ejaculation. For instance, in August 2023,
Maude, a US-based sexual wellness company, launched Stay, a delay spray
explicitly designed to address premature ejaculation. This product is
infused with 10% lidocaine, a fast-evaporating local anesthetic that
reduces sensitivity in the male genital region. Furthermore, Stay is
compatible with both latex and polyisoprene condoms, as well as various
lubricants and devices. It's vegan-friendly, fragrance-free, and free
from sulfates, silicones, and parabens.
The premature ejaculation treatment market covered in this report is segmented –
1) By Type: Antidepressants (SSRIs), Phosphodiesterase-5 Inhibitors, Topical Anesthetics, Analgesics, Other Treatment
2) By Route of Administration: Oral, Topical
3) By Distribution Channel: Retail, Direct-To-Consumer
4) By Application: Hospital, Retail Pharmacy, Online Pharmacy, Other Applications
Get an inside scoop of the premature ejaculation treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13518&type=smp
Regional Insights -
North
America was the largest region in the premature rjaculation treatment
market in 2023, and is expected to be the fastest-growing region in the
forecast period. The regions covered in the premature ejaculation
treatment market report are Asia-Pacific, Western Europe, Eastern
Europe, North America, South America, Middle East, Africa.
Key Companies -
Major
companies operating in the premature ejaculation treatment market
report are Pfizer Inc., Johnson & Johnson, Merck & Co Inc.,
AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca PLC, GlaxoSmithKline
plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva
Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun
Pharmaceutical Industries Ltd., Menarini Group, Lupin Limited., Amneal
Pharmaceuticals Inc., Mankind Pharma Ltd., Cipla Limited, Alembic
Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., ANI
Pharmaceuticals Inc., Sagent Pharmaceuticals Inc., Vivus Inc.,
Absorption Pharmaceuticals LLC, Innovus Pharmaceuticals Inc., Sunrise
Pharmaceuticals Inc., Solco Healthcare US LLC, Apricus Biosciences Inc.,
Regent Pacific Group Limited, Endurance RP Ltd.
Table of Contents
1. Executive Summary
2. Premature Ejaculation Treatment Market Report Structure
3. Premature Ejaculation Treatment Market Trends And Strategies
4. Premature Ejaculation Treatment Market – Macro Economic Scenario
5. Premature Ejaculation Treatment Market Size And Growth
…..
27. Premature Ejaculation Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment